Whole genome CRISPR/Cas9 gene knockout screens consistently identify loss of BAX as a resistance factor to MCL-1-targeting BH3-mimetic drugs in Eμ-Myc mouse lymphoma cells. The gene discussed is MYC; the disease is lymphoma.